253 related articles for article (PubMed ID: 30422249)
21. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
[TBL] [Abstract][Full Text] [Related]
22. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
23. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
24. Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study.
Yanes M; Santoni G; Maret-Ouda J; Markar S; Ness-Jensen E; Kauppila J; Färkkilä M; Lynge E; Pukkala E; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Gastroenterology; 2021 Jun; 160(7):2283-2290. PubMed ID: 33587926
[TBL] [Abstract][Full Text] [Related]
25. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
[TBL] [Abstract][Full Text] [Related]
26. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
27. Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.
Markar SR; Arhi C; Wiggins T; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2020 Apr; 271(4):709-715. PubMed ID: 30499807
[TBL] [Abstract][Full Text] [Related]
28. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
29. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
30. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study.
Tran T; Spechler SJ; Richardson P; El-Serag HB
Am J Gastroenterol; 2005 May; 100(5):1002-8. PubMed ID: 15842570
[TBL] [Abstract][Full Text] [Related]
31. Hospital Volume of Antireflux Surgery in Relation to Endoscopic and Surgical Re-interventions.
Markar S; Santoni G; Maret-Ouda J; Artama M; Färkkilä M; Lynge E; Pukkala E; Ness-Jensen E; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e1138-e1143. PubMed ID: 31913870
[TBL] [Abstract][Full Text] [Related]
32. Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study.
Wiklund AK; Santoni G; Yan J; Radkiewicz C; Xie S; Birgisson H; Ness-Jensen E; von Euler-Chelpin M; Kauppila JH; Lagergren J
Gastroenterology; 2024 Mar; ():. PubMed ID: 38513743
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
34. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
35. Use of healthcare resources among medically and surgically treated patients with gastroesophageal reflux disease: a population-based study.
Holzman MD; Mitchel EF; Ray WA; Smalley WE
J Am Coll Surg; 2001 Jan; 192(1):17-24. PubMed ID: 11192919
[TBL] [Abstract][Full Text] [Related]
36. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
37. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
Erichsen R; Robertson D; Farkas DK; Pedersen L; Pohl H; Baron JA; Sørensen HT
Clin Gastroenterol Hepatol; 2012 May; 10(5):475-80.e1. PubMed ID: 22245963
[TBL] [Abstract][Full Text] [Related]
38. Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.
Wang SM; Freedman ND; Katki HA; Matthews C; Graubard BI; Kahle LL; Abnet CC
Cancer; 2021 Jun; 127(11):1871-1879. PubMed ID: 33615447
[TBL] [Abstract][Full Text] [Related]
39. Antireflux surgery and the risk of esophageal adenocarcinoma: an antithetical view of the data from sweden.
DeMeester SR
Ann Surg; 2013 Apr; 257(4):583-5. PubMed ID: 23470506
[No Abstract] [Full Text] [Related]
40. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
